Table 2.
Total (N = 4670) | |
---|---|
Frequency of symptoms at admission, n (%) | |
Headache | 2721 (58.3) |
Cough | 2648 (56.7) |
Myalgias | 2489 (53.3) |
Fever | 2236 (47.9) |
Arthralgia | 2009 (43.0) |
Pharyngodynia | 1659 (35.5) |
Anosmia | 1056 (22.6) |
Dysgeusia | 1015 (21.7) |
Rhinorrhea | 1002 (21.5) |
Diarrhea | 655 (14.0) |
Conjunctivitis | 445 (9.5) |
Main clinical conditions during hospitalization | |
Duration of symptoms prior to admission | 7 (4–10) |
0–5 days, n (%) | 1730 (37) |
>5 days, n (%) | 2899 (62.1) |
No registry, n (%) | 41 (0.9) |
NEWS score at admission | 3 (2–4) |
Green, n (%) | 3592 (76.9) |
Yellow, n (%) | 669 (14.3) |
Red, n (%) | 154 (3.3) |
No registry, n (%) | 255 (5.5) |
CALL score on admission | 7 (4–8) |
Steroid treatment at hospitalization, n (%) | 2057 (44.1) |
High-flow nasal cannula requirement, n (%) | 710 (15.2) |
ICU admission, n (%) | 216 (4.6) |
Invasive mechanical ventilation requirement, n (%) | 212 (4.5) |
ICU duration, days | 8 (5–14) |
Hospitalization stay, days | 8 (6–12) |
Outcome, n (%) | |
Discharge | 4642 (99.4) |
Referred | 28 (0.6) |
Laboratory results during hospitalization | |
Hemoglobin (mg/dL) | 13.9 (12.8−14.9) |
Low hemoglobin (<12.5 mg/dL) | 856 (18.3) |
D-dimer (ng/mL) | 540 (340−1010) |
D-dimer categories, n (%) | |
Normal level | 2028 (43.4) |
500 to1000 ng/mL | 934 (20) |
>1000 to <1500 ng/mL | 392 (8.4) |
⩾1500 ng/mL | 614 (13.2) |
Ferritin (µg/L) | 283.3 (116.5−591.6) |
High level (>336.2 µg/L), n (%) | 1456 (31.2) |
Lactic dehydrogenase (UI/L) | 206 (165−264) |
High level (>233 UI/L), n (%) | 1435 (30.7) |
Absolute lymphocytes (×103 cells/μL) | 1267.2 (861−1793.4) |
<1000 (×103 cells/μL), n (%) | 1475 (31.6) |
Glucose (mg/dL) | 126 (101−167) |
Glucose (>100 mg/dL), n (%) | 2498 (53.5) |
CALL, comorbidity, age, lymphocyte count, and lactate dehydrogenase; ICU, intensive care unit; NEWS, National Early Warning Score.
Data are presented as median (interquartile range) unless otherwise stated.